For the 5th year in a row DFE Pharma is organising the Dry Powder Inhalation China technology conference in Shanghai, China (March 22nd - 24th, 2017). Last year this growing event was attended by over 200 inhalation industry professionals ranging from R&D and General Management to government officials, signalling the growing importance of DPI formulations for the Chinese Pharmaceutical industry.
The purpose of DPI China is to share the latest technological developments within the global DPI market with Chinese customers and institutes. Presentations will be held by experts in the field of dry powder inhaler products representing the full chain of product development.
DFE Pharma partnered with multiple companies having diverse expertise needed to successfully develop an inhalable formulation. DFE Pharma continuously works on Inhalation development projects in the Chinese Pharmaceutical industry, as well as for the inhalation industry worldwide.